Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | matrix metallopeptidase 14 (membrane-inserted) | Starlite/ChEMBL | References |
Homo sapiens | matrix metallopeptidase 1 (interstitial collagenase) | Starlite/ChEMBL | References |
Homo sapiens | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | Starlite/ChEMBL | References |
Homo sapiens | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | Starlite/ChEMBL | References |
Homo sapiens | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Matrixin family protein | matrix metallopeptidase 1 (interstitial collagenase) | 403 aa | 401 aa | 27.7 % |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 477 aa | 431 aa | 34.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | ERG2 and Sigma1 receptor like protein | 0.0386 | 0.3238 | 1 |
Loa Loa (eye worm) | matrixin family protein | 0.0367 | 0.3006 | 0.4061 |
Loa Loa (eye worm) | hypothetical protein | 0.0203 | 0.1041 | 0.1406 |
Plasmodium falciparum | isoleucine--tRNA ligase, putative | 0.033 | 0.2563 | 0.5 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.0141 | 0.0302 | 0.0933 |
Loa Loa (eye worm) | matrixin family protein | 0.0257 | 0.1688 | 0.228 |
Schistosoma mansoni | sodium/chloride dependent neurotransmitter transporter | 0.0734 | 0.7402 | 1 |
Wolbachia endosymbiont of Brugia malayi | formamidopyrimidine-DNA glycosylase | 0.03 | 0.2202 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0197 | 0.0978 | 0.1321 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.0386 | 0.3238 | 0.5 |
Onchocerca volvulus | 0.0164 | 0.0579 | 0.2123 | |
Mycobacterium ulcerans | formamidopyrimidine-DNA glycosylase | 0.03 | 0.2202 | 0.1959 |
Loa Loa (eye worm) | hypothetical protein | 0.0734 | 0.7402 | 1 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0257 | 0.1688 | 0.6186 |
Mycobacterium tuberculosis | Probable formamidopyrimidine-DNA glycosylase Fpg (FAPY-DNA glycosylase) | 0.03 | 0.2202 | 0.1959 |
Mycobacterium leprae | Probable formamidopyrimidine-DNA glycosylase Fpg (FAPY-DNA GLYCOSYLASE) | 0.03 | 0.2202 | 1 |
Schistosoma mansoni | matrix metallopeptidase-7 (M10 family) | 0.0203 | 0.1041 | 0.0677 |
Loa Loa (eye worm) | hypothetical protein | 0.0141 | 0.0302 | 0.0408 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0951 | 1 | 1 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.0386 | 0.3238 | 0.5 |
Mycobacterium ulcerans | formamidopyrimidine-DNA glycosylase | 0.03 | 0.2202 | 0.1959 |
Mycobacterium tuberculosis | Possible DNA glycosylase | 0.03 | 0.2202 | 0.1959 |
Echinococcus multilocularis | sodium:chloride dependent neurotransmitter | 0.0734 | 0.7402 | 1 |
Onchocerca volvulus | Matrilysin homolog | 0.0344 | 0.2729 | 1 |
Brugia malayi | Hemopexin family protein | 0.0164 | 0.0579 | 0.1789 |
Leishmania major | C-8 sterol isomerase-like protein | 0.0386 | 0.3238 | 0.5 |
Brugia malayi | Matrixin family protein | 0.0367 | 0.3006 | 0.9282 |
Loa Loa (eye worm) | hypothetical protein | 0.0386 | 0.3238 | 0.4375 |
Schistosoma mansoni | sodium/chloride dependent neurotransmitter transporter | 0.0734 | 0.7402 | 1 |
Schistosoma mansoni | sodium/chloride dependent neurotransmitter transporter | 0.0734 | 0.7402 | 1 |
Echinococcus granulosus | sodium:chloride dependent neurotransmitter | 0.0734 | 0.7402 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0734 | 0.7402 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 7.32 | Inhibition of MMP3 (unknown origin) | ChEMBL. | 17275314 |
IC50 (binding) | = 9.47 | Inhibition of MMP2 (unknown origin) | ChEMBL. | 17275314 |
IC50 (binding) | = 0.34 nM | Ability to inhibit the matrix metalloproteinase-2 by method of Knight et al using the fluorogenic peptide substrate. | ChEMBL. | 11229773 |
IC50 (binding) | = 0.34 nM | Ability to inhibit the matrix metalloproteinase-2 by method of Knight et al using the fluorogenic peptide substrate. | ChEMBL. | 11229773 |
IC50 (binding) | = 0.38 nM | Concentration required to inhibit the catalytic domain Matrix metalloproteinase-2 using Nagase fluorogenic as a substrate. | ChEMBL. | 11229774 |
IC50 (binding) | = 0.38 nM | Concentration required to inhibit the catalytic domain Matrix metalloproteinase-2 using Nagase fluorogenic as a substrate. | ChEMBL. | 11229774 |
IC50 (binding) | = 1.3 nM | Activity against Matrix metalloproteinase-9 (MMP-9). | ChEMBL. | 9548812 |
IC50 (binding) | = 1.3 nM | Activity against Matrix metalloproteinase-9 (MMP-9). | ChEMBL. | 9548812 |
IC50 (binding) | = 1.9 nM | Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1) | ChEMBL. | 9548812 |
IC50 (binding) | = 1.9 nM | Activity against deletion mutant of MT1-MMP lacking the transmembrane domain (deltaMT1) | ChEMBL. | 9548812 |
IC50 (binding) | = 21 nM | Activity against Matrix metalloproteinase-1 (MMP-1). | ChEMBL. | 9548812 |
IC50 (binding) | = 21 nM | Activity against Matrix metalloproteinase-1 (MMP-1). | ChEMBL. | 9548812 |
IC50 (binding) | = 48 nM | Concentration required to inhibit the catalytic domain Matrix metalloproteinase-3 using Nagase fluorogenic as a substrate. | ChEMBL. | 11229774 |
IC50 (binding) | = 48 nM | Ability to inhibit the matrix metalloproteinase-3 by method of Knight et al using the fluorogenic peptide substrate. | ChEMBL. | 11229773 |
IC50 (binding) | = 48 nM | Concentration required to inhibit the catalytic domain Matrix metalloproteinase-3 using Nagase fluorogenic as a substrate. | ChEMBL. | 11229774 |
IC50 (binding) | = 48 nM | Ability to inhibit the matrix metalloproteinase-3 by method of Knight et al using the fluorogenic peptide substrate. | ChEMBL. | 11229773 |
log(1/IC50) (binding) | = 7.32 | Inhibition of MMP3 (unknown origin) | ChEMBL. | 17275314 |
log(1/IC50) (binding) | = 9.47 | Inhibition of MMP2 (unknown origin) | ChEMBL. | 17275314 |
Ratio (binding) | = 0 | The selectivity ratio of the compound to Matrix metalloproteinase-2 and Matrix metalloproteinase-3 = 1/141 | ChEMBL. | 11229773 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
4 literature references were collected for this gene.